You won’t fix what you don’t value: Two reasons why traditional cost-effective analyses can perpetuate health inequities

A new report from Partnership for Health Analytic Research or PHAR describes how value assessments that use traditional cost-effectiveness analyses can overlook important health disparities and risk...
Read More
Recognizing LGBTQ+ Pride in biopharmaceutical science

June is Pride Month and, like many across the country, we look forward to celebrating the importance of equality and reminding ourselves to continually seek opportunities to make our society more...
Read More
Potential gene therapies bring hope to patients with sickle cell disease

A recent analysis highlights how potential gene therapies have the potential to dramatically reduce income disparities for patients with sickle cell disease, leading to as much as $21,000 more in...
Read More
Addressing social determinants of health to improve equitable access to medicines

PhRMA Awards $150,000 to Address Social Determinants of Health:Announcing the Recipients of Round 4 of the PhRMA Collaborative Actions to Reach Equity (CAREs) Grant Program As part of PhRMA’s...
Read More
Stephanie Dyson of BMS on reducing health disparities

Conversations and healthy debate about issues facing our industry and the health care system are critical to addressing some of today’s challenges and opportunities. The PhRMA blog welcomes guest...
Read More
The biopharmaceutical industry leads in helping women achieve new heights, according to IAM’s diversity 100

“Phenomenal pharma” – that’s how a recent report by IAM described the biopharmaceutical industry’s leadership in inventor diversity. The report accompanied the release of IAM’s Diversity 100 list,...
Read More
Sharing rebates can save Americans with diabetes $500 each year and improve adherence, especially for Black and Hispanic Americans

A new study by GlobalData looked at brand oral antidiabetic drugs (OADs) and found that sharing negotiated rebates with patients in commercial health plans at the pharmacy counter can help lower...
Read More
Recap: Our inaugural graduate summit and career expo

On October 27 and 28, 2021, PhRMA held our inaugural graduate summit and career expo, Pathways to Success in Biopharma. As part of a joint partnership between PhRMA, CHI, UNCF and the Ernest E. Just...
Read More
Announcing CAREs Grant Round 4

Medicines can be critical to treating, managing, and sometimes curing illnesses, thereby offering an effective tool to improve health outcomes and reduce health disparities. However, numerous studies...
Read More
Upcoming graduate student summit will showcase pathways to success within the biopharmaceutical industry

I am excited to join with Dr. Michael L. Lomax, President & CEO, UNCF; Dr. James Gillespie, President & Co-Founder, Center for Healthcare Innovation (CHI); and Dr. Chad Womack, Co-Founder and...
Read More